We are live on ! Find out more
LABD icon

Direxion Daily S&P Biotech Bear 3X ETF
LABD

12 hedge funds and large institutions have $8.41M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more call options, than puts

Call options by funds: $610K | Put options by funds: $549K

0% less ownership

Funds ownership: 0.01% → 0% (-0%)

33% less funds holding

Funds holding: 18 → 12 (-6)

64% less capital invested

Capital invested by funds: $23.1M → $8.41M (-$14.7M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

83% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 6

Holders
12
Holders Change
-6
Holders Change %
-33.33%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
6
Closed
6
Calls
$610K
Puts
$549K
Net Calls
+$61K
Net Calls Change
+$773K

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$362K
2
Jane Street
Jane Street
New York
+$362K
3
HF
HRT Financial
New York
+$84.4K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$3.92M
2
VF
Virtu Financial
New York
-$2.25M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.33M
4
CS
Credit Suisse
Switzerland
-$1.03M
5
TSS
Two Sigma Securities
New York
-$526K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
1
Citigroup
New York
$5.29M -$3.92M -325 -36%
SG Americas Securities
2
SG Americas Securities
New York
$1.54M – – –
TRCT
3
Tower Research Capital (TRC)
New York
$435K -$338K -28 -38%
Jane Street
4
Jane Street
New York
$336K +$362K +30 +429%
Barclays
5
Barclays
United Kingdom
$276K +$362K +30 New
HF
6
HRT Financial
New York
$169K +$84.4K +7 +64%
VF
7
Virtu Financial
New York
$121K -$2.25M -187 -94%
CT
8
CMT Trading
Illinois
$86K -$24.1K -2 -18%
Goldman Sachs
9
Goldman Sachs
New York
$70K – – –
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$67K -$1.33M -110 -94%
CG
11
Cutler Group
California
$15K – – –
Simplex Trading
12
Simplex Trading
Illinois
$8K -$60.3K -5 -83%
Morgan Stanley
13
Morgan Stanley
New York
$2K -$24.1K -2 Closed
TWA
14
TCI Wealth Advisors
Arizona
$2K – – –
CS
15
Credit Suisse
Switzerland
– -$1.03M -75 Closed
TSS
16
Two Sigma Securities
New York
– -$526K -38 Closed
Citadel Advisors
17
Citadel Advisors
Florida
– -$326K -27 Closed
TCM
18
Tradewinds Capital Management
Washington
– -$69K -5 Closed
UBS Group
19
UBS Group
Switzerland
– -$34K -2 Closed

LABD Hedge Fund Activity: Q3 2017 in Review

12 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2017, worth a combined $8.41M — down 64% from $23.1M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of LABD and 1 opened new positions — a net loss of 5 holders — while 6 trimmed existing stakes and 2 added.

The largest buyer was Barclays, opening a new position worth an estimated $362K. The largest seller was Citigroup, cutting an estimated $3.92M.

  • 12 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2017, down from 18 in Q2 2017.
  • Funds reported $8.41M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2017, down 64% quarter-over-quarter.
  • 1 fund opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2017 and 6 closed out, a net change of -5 holders.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2017 was Barclays, an estimated $362K added.
  • The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2017 was Citigroup, an estimated $3.92M sold.

Based on aggregated 13F filings for Q3 2017.